Financials
Income statement
| Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|
| Total reported revenue | 38.1B | 37.2B | 34.2B | 32.5B |
| Cost of revenue | 28.6B | 26.5B | 24.7B | 23.8B |
| Gross profit | 9.4B | 10.7B | 9.5B | 8.7B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | 4.1B | 3.9B | 3.1B | 2.9B |
| Non operating interest income | ||||
| Income | 240M | 155M | 217M | 165M |
| Expense | 125M | -8M | 23M | 4M |
| Other income expense | — | — | — | — |
| Pretax income | 4.4B | 3.9B | 4.1B | 4.0B |
| Tax provision | 1.0B | 944M | 1.4B | 847M |
| Net income | 3.4B | 3.0B | 2.6B | 3.1B |
| Basic EPS | — | — | — | 58.3 |
| Diluted EPS | — | — | — | 50.1 |
| Basic average shares | — | — | — | 53.6M |
| Diluted average shares | — | — | — | 62.3M |
| EBITDA | 6.0B | 5.2B | 5.4B | 5.2B |
| Net income from continuing op. | 4.4B | 3.9B | 4.1B | 4.0B |
| Minority interests | -10M | -12M | -10M | -17M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |